Hemeo
Amsterdam, NL · Founded 2019 · 3 employees on LinkedIn · 1 known investors
Find your way into Hemeo
146 people in our graph share verified history with the Hemeo team — schools, employers, funds. One of them is your warm intro.
René Kuijtenunlockedknows Rene van den Ham · together at Utrecht University (overlapped)
×11knows the team · via Utrecht University
Hemeo develops AI-based clinical decision support software that consolidates data from multiple sources to predict coagulation risks and personalize the prevention and treatment of bleeding and thrombosis. It is aimed at doctors managing coagulation complications, with the goal of reducing blood transfusions and improving patient survival.
Founders & leadership
Hemeo was founded in 2019 by Rene van den Ham.
RV
Rene van den HaminCo-founder, Chief Technology OfficerRene van den Ham has 5+ years of experience in academic life sciences research and 15+ years in industrial medical device development, with expertise in data, AI, and software as a medical device. He is founder of Hemeo, which develops AI-based clinical decision support software to predict coagulation risks and personalize bleeding and thrombosis treatment.
Investors · 1
Frequently asked questions
- What does Hemeo do?
- Hemeo develops AI-based clinical decision support software that consolidates data from multiple sources to predict coagulation risks and personalize the prevention and treatment of bleeding and thrombosis. It is aimed at doctors managing coagulation complications, with the goal of reducing blood transfusions and improving patient survival.
- Who founded Hemeo?
- Hemeo was founded by Rene van den Ham in 2019.
- Who are Hemeo's investors?
- Hemeo's investors include NLC.
- Where is Hemeo headquartered?
- Hemeo is headquartered in Amsterdam, NL.